MedTrace Logo

Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

NCT02005146 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2015-05-01

No results posted yet for this study

Summary

Define the patients who lost HBsAg, studying the loss predictive factors and if there was suspension of treatment, study the evolution after that

Conditions

  • Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues

Sponsors & Collaborators

  • Fundación Pública Andaluza Progreso y Salud

    lead OTHER

Principal Investigators

  • Emilio Suárez García · Hospital Universitario Virgen de Valme

  • Miguel Ángel Simón Marco · Hospital Clínico Universitario Lozano Blesa

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02005146 on ClinicalTrials.gov